Showing 1131-1140 of 3103 results for "".
Advance Care Planning in Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/advance-care-planning-in-amyotrophic-lateral-sclerosis/31809/Focusing on feelings, facts, and family is useful in shared decision making.Muscle MRI for Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/muscle-mri-for-neuromuscular-disorders/31687/Using muscle MRI to diagnose neuromuscular conditions requires awareness of different patterns of muscle involvement.Therapeutic Approaches to Neuromuscular Repeat Disorders: Facioscapulohumeral Muscular Dystrophy and Myotonic Dystrophy Type 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/therapeutic-approaches-to-neuromuscular-repeat-disorders-facioscapulohumeral-muscular-dystrophy-and-myotonic-dystrophy-type-1/32027/A promising pipeline of therapeutics target toxic RNA.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
Machine Learning–Based Neuroimaging in Epilepsy: Improving Detection of Epileptogenic Lesions
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/machine-learningbased-neuroimaging-in-epilepsy-improving-detection-of-epileptogenic-lesions/57247/Machine learning tools are transforming the detection of epileptogenic lesions that are frequently missed on conventional MRI, with several pipelines now validated across international epilepsy centers.The Unrecognized Value of Neurohospitalist Fellowships-Reframing Perspectives
https://practicalneurology.com/archives/2025-mar/the-unrecognized-value-of-neurohospitalist-fellowships-reframing-perspectives/35449/Neurohospitalist fellowships enhance clinical expertise and provide a foundation in leadership, research, and systems administration, empowering future neurologists to thrive in an evolving health care landscape while improving patient outcomes.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Single Isolated Concussion Part I: Definitions, Classification, and Prognosis
https://practicalneurology.com/diseases-diagnoses/tbi/single-isolated-concussion-part-i-definitions-classification-and-prognosis/30268/Providing sound advice after a single isolated concussion.Full Disclosure: How To Apologize For Medical Errors
https://practicalneurology.com/columns/practice-management/full-disclosure-how-to-apologize-for-medical-errors/30789/Of all the bad news physicians give patients, “I'm sorry” seems the most dangerous. Here, we look at how to confront disclosure and why the gold standard treatment for a medical error should be an apology